Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M A DimopoulosS P Treon
Leukemia & Lymphoma
G Majumdar, N G Slater
JPMA. the Journal of the Pakistan Medical Association
Safoorah KhalidMohammad Khurshid
Peripheral capillary non-perfusion in asymptomatic Waldenström's macroglobulinemia
(opens in new tab)BMC Ophthalmology
Chryssanthi KoutsandreaIoannis Ladas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
S P TreonAshraf Badros